Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Moodys
AstraZeneca
Harvard Business School
Chubb
Dow
QuintilesIMS
Novartis
Cantor Fitzgerald
Mallinckrodt

Generated: February 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 010151

« Back to Dashboard

NDA 010151 describes DILANTIN, which is a drug marketed by Parke-davis, Parke Davis, and Pfizer, and is included in four NDAs. It is available from eleven suppliers. Additional details are available on the DILANTIN profile page.

The generic ingredient in DILANTIN is phenytoin. There are nineteen drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the phenytoin profile page.
Summary for 010151
Tradename:DILANTIN
Applicant:Parke Davis
Ingredient:phenytoin sodium
Patents:0
Therapeutic Class:Anticonvulsants
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength50MG/ML
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Chinese Patent Office
Covington
US Army
Federal Trade Commission
Healthtrust
Cerilliant
Moodys
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot